The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Valsartan Drug Market Research Report 2024
Synopsis
Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.
The global Valsartan Drug market was valued at US$ 589 million in 2023 and is anticipated to reach US$ 866.2 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Valsartan Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan Drug.
Report Scope
The Valsartan Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valsartan Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valsartan Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
Segment by Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets
Segment by Application
Hypertension
Heart Failure
Heart Attack
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valsartan Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valsartan Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.
The global Valsartan Drug market was valued at US$ 589 million in 2023 and is anticipated to reach US$ 866.2 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Valsartan Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan Drug.
Report Scope
The Valsartan Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valsartan Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valsartan Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
Segment by Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets
Segment by Application
Hypertension
Heart Failure
Heart Attack
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valsartan Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valsartan Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Valsartan Drug Market Overview
1.1 Product Overview and Scope of Valsartan Drug
1.2 Valsartan Drug Segment by Type
1.2.1 Global Valsartan Drug Market Value Comparison by Type (2024-2030)
1.2.2 40 mg Tablets
1.2.3 80 mg Tablets
1.2.4 160 mg Tablets
1.2.5 320 mg Tablets
1.3 Valsartan Drug Segment by Application
1.3.1 Global Valsartan Drug Market Value by Application: (2024-2030)
1.3.2 Hypertension
1.3.3 Heart Failure
1.3.4 Heart Attack
1.4 Global Valsartan Drug Market Size Estimates and Forecasts
1.4.1 Global Valsartan Drug Revenue 2019-2030
1.4.2 Global Valsartan Drug Sales 2019-2030
1.4.3 Global Valsartan Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valsartan Drug Market Competition by Manufacturers
2.1 Global Valsartan Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valsartan Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valsartan Drug Average Price by Manufacturers (2019-2024)
2.4 Global Valsartan Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valsartan Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valsartan Drug, Product Type & Application
2.7 Valsartan Drug Market Competitive Situation and Trends
2.7.1 Valsartan Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valsartan Drug Players Market Share by Revenue
2.7.3 Global Valsartan Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valsartan Drug Retrospective Market Scenario by Region
3.1 Global Valsartan Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valsartan Drug Global Valsartan Drug Sales by Region: 2019-2030
3.2.1 Global Valsartan Drug Sales by Region: 2019-2024
3.2.2 Global Valsartan Drug Sales by Region: 2025-2030
3.3 Global Valsartan Drug Global Valsartan Drug Revenue by Region: 2019-2030
3.3.1 Global Valsartan Drug Revenue by Region: 2019-2024
3.3.2 Global Valsartan Drug Revenue by Region: 2025-2030
3.4 North America Valsartan Drug Market Facts & Figures by Country
3.4.1 North America Valsartan Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valsartan Drug Sales by Country (2019-2030)
3.4.3 North America Valsartan Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valsartan Drug Market Facts & Figures by Country
3.5.1 Europe Valsartan Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valsartan Drug Sales by Country (2019-2030)
3.5.3 Europe Valsartan Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valsartan Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Valsartan Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valsartan Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Valsartan Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valsartan Drug Market Facts & Figures by Country
3.7.1 Latin America Valsartan Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valsartan Drug Sales by Country (2019-2030)
3.7.3 Latin America Valsartan Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valsartan Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Valsartan Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valsartan Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valsartan Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valsartan Drug Sales by Type (2019-2030)
4.1.1 Global Valsartan Drug Sales by Type (2019-2024)
4.1.2 Global Valsartan Drug Sales by Type (2025-2030)
4.1.3 Global Valsartan Drug Sales Market Share by Type (2019-2030)
4.2 Global Valsartan Drug Revenue by Type (2019-2030)
4.2.1 Global Valsartan Drug Revenue by Type (2019-2024)
4.2.2 Global Valsartan Drug Revenue by Type (2025-2030)
4.2.3 Global Valsartan Drug Revenue Market Share by Type (2019-2030)
4.3 Global Valsartan Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Valsartan Drug Sales by Application (2019-2030)
5.1.1 Global Valsartan Drug Sales by Application (2019-2024)
5.1.2 Global Valsartan Drug Sales by Application (2025-2030)
5.1.3 Global Valsartan Drug Sales Market Share by Application (2019-2030)
5.2 Global Valsartan Drug Revenue by Application (2019-2030)
5.2.1 Global Valsartan Drug Revenue by Application (2019-2024)
5.2.2 Global Valsartan Drug Revenue by Application (2025-2030)
5.2.3 Global Valsartan Drug Revenue Market Share by Application (2019-2030)
5.3 Global Valsartan Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Valsartan Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sun Pharmaceutical
6.2.1 Sun Pharmaceutical Corporation Information
6.2.2 Sun Pharmaceutical Description and Business Overview
6.2.3 Sun Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sun Pharmaceutical Valsartan Drug Product Portfolio
6.2.5 Sun Pharmaceutical Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Valsartan Drug Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Valsartan Drug Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Alembic Pharmaceuticals
6.5.1 Alembic Pharmaceuticals Corporation Information
6.5.2 Alembic Pharmaceuticals Description and Business Overview
6.5.3 Alembic Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alembic Pharmaceuticals Valsartan Drug Product Portfolio
6.5.5 Alembic Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lupin Valsartan Drug Product Portfolio
6.6.5 Lupin Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Valsartan Drug Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Macleods Pharmaceuticals
6.8.1 Macleods Pharmaceuticals Corporation Information
6.8.2 Macleods Pharmaceuticals Description and Business Overview
6.8.3 Macleods Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Macleods Pharmaceuticals Valsartan Drug Product Portfolio
6.8.5 Macleods Pharmaceuticals Recent Developments/Updates
6.9 HETERO
6.9.1 HETERO Corporation Information
6.9.2 HETERO Description and Business Overview
6.9.3 HETERO Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 HETERO Valsartan Drug Product Portfolio
6.9.5 HETERO Recent Developments/Updates
6.10 Torrent Pharmaceuticals
6.10.1 Torrent Pharmaceuticals Corporation Information
6.10.2 Torrent Pharmaceuticals Description and Business Overview
6.10.3 Torrent Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Torrent Pharmaceuticals Valsartan Drug Product Portfolio
6.10.5 Torrent Pharmaceuticals Recent Developments/Updates
6.11 Huaren Pharmaceutical
6.11.1 Huaren Pharmaceutical Corporation Information
6.11.2 Huaren Pharmaceutical Valsartan Drug Description and Business Overview
6.11.3 Huaren Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huaren Pharmaceutical Valsartan Drug Product Portfolio
6.11.5 Huaren Pharmaceutical Recent Developments/Updates
6.12 Jubilant Pharma
6.12.1 Jubilant Pharma Corporation Information
6.12.2 Jubilant Pharma Valsartan Drug Description and Business Overview
6.12.3 Jubilant Pharma Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jubilant Pharma Valsartan Drug Product Portfolio
6.12.5 Jubilant Pharma Recent Developments/Updates
6.13 Amneal Pharmaceuticals
6.13.1 Amneal Pharmaceuticals Corporation Information
6.13.2 Amneal Pharmaceuticals Valsartan Drug Description and Business Overview
6.13.3 Amneal Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Amneal Pharmaceuticals Valsartan Drug Product Portfolio
6.13.5 Amneal Pharmaceuticals Recent Developments/Updates
6.14 Zhejiang Huahai Pharmaceutical
6.14.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.14.2 Zhejiang Huahai Pharmaceutical Valsartan Drug Description and Business Overview
6.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolio
6.14.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.15 Square Pharmaceuticals
6.15.1 Square Pharmaceuticals Corporation Information
6.15.2 Square Pharmaceuticals Valsartan Drug Description and Business Overview
6.15.3 Square Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Square Pharmaceuticals Valsartan Drug Product Portfolio
6.15.5 Square Pharmaceuticals Recent Developments/Updates
6.16 Unichem Laboratories
6.16.1 Unichem Laboratories Corporation Information
6.16.2 Unichem Laboratories Valsartan Drug Description and Business Overview
6.16.3 Unichem Laboratories Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Unichem Laboratories Valsartan Drug Product Portfolio
6.16.5 Unichem Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valsartan Drug Industry Chain Analysis
7.2 Valsartan Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valsartan Drug Production Mode & Process
7.4 Valsartan Drug Sales and Marketing
7.4.1 Valsartan Drug Sales Channels
7.4.2 Valsartan Drug Distributors
7.5 Valsartan Drug Customers
8 Valsartan Drug Market Dynamics
8.1 Valsartan Drug Industry Trends
8.2 Valsartan Drug Market Drivers
8.3 Valsartan Drug Market Challenges
8.4 Valsartan Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
